What is Versa Cardio?
Versa Cardio operates at the intersection of medical technology and clinical efficiency, specializing in advanced ECG diagnostics. The company's flagship innovation, the V-Patch, represents a paradigm shift in cardiac monitoring by facilitating a three-minute patient hookup and continuous, near-real-time data collection. By eliminating the need for cumbersome lead wires and long-term service contracts, Versa Cardio addresses critical pain points for physicians, medical groups, and hospitals. The technology not only enhances the detection of irregular heart rhythms but also optimizes operational workflows, ultimately driving improved patient retention and clinical outcomes across the healthcare continuum.
How much funding has Versa Cardio raised?
Versa Cardio has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Versa Cardio
PPP
Public-Private Partnership
What's next for Versa Cardio?
With the recent infusion of capital, Versa Cardio is poised to scale its operations and expand its footprint in the diagnostic services market. The company's strategic roadmap likely involves deepening its integration within hospital networks and enhancing its data analytics capabilities to provide more actionable insights for clinicians. As the demand for remote, non-invasive diagnostic tools continues to rise, Versa Cardio is strategically positioned to capitalize on these industry tailwinds. Future growth will likely focus on broadening the clinical applications of the V-Patch and strengthening its competitive moat through continued technological refinement and strategic partnerships within the broader digital health ecosystem.
See full Versa Cardio company page
